To this point, it is noteworthy that SS-31 has been shown to alter cytochrome c interactions with CL-containing bilayers (10, 11) and to reduce mitochondrial damage in models of Alzheimer's and Parkinson's disease (61, 62). Here, CYCS is linked to Parkinson disease.